Analysis on Traditional Chinese Medicine Syndrome of Novel Coronavirus./ 新型冠状病毒肺炎的中医证型分析

Objective：To analyze the characteristics of TCM syndromes in patients with Novel Coronavirus Pneumonia (COVID-19), and to provide reference for further clinical treatment of COVID-19 patients Methods: Confirmed NPC cases collected from several hospitals in Hubei and Sichuan from February 1 to February 14, 2020 were included, then the basic characteristics (age, gender, source), clinical classification and TCM syndrome types were collected The distribution characteristics of TCM syndromes in patients with different clinical types were analyzed by SPSS 26 0 statistical software Results: A total of 138 COVID-19 patients were collected, 120/18 from Hubei / Sichuan, with a male-to-female ratio of 0 86: 1 and an average age of 53 2 ± 14 9 years 86 patients (62 3%) were under 60 years of age There were 80 cases of general type and 58 cases of severe type The morbidity age in severe type group (57 7 ± 14 6) was higher than that in the general group (49 9 ± 14 4) TCM syndromes are mainly distributed in 44 cases (31 9%) of “Shieweiyang” syndrome, 28 cases (20 3%) of “Shierefu” syndrome, 36 cases (26 1%) of “Shirexifei, Feishixuanjiang” syndrome, and others 19 cases (13 8%) of “Shirexufei, Yangqixunei, Feiqiyujue” Syndrome, 11 cases (8%) of “Shirexifei, Qiyinliangshang, Feiqiyujue” Syndrome It was observed that distribution of various types of syndromes was not uniform (2 = 0 202, P <0 05) Further analysis showed that: In general group, “Shieweiyag” (48 8%), “Shierefu” (26 3%) and “Shirexifei, Feishixuanjiang” (17 5%) were the main syndromes In severe group, “Shirexifei, Feishixuanjiang” (37 9%) and “Shirexifei, Yangqixunei, Feiqiyujue” (25 9%) were the main syndromes, and the distribution of each syndrome was different between the general group and the severe group (Z = 6 452, P < 0 05) Conclusion: TCM Syndromes of COVID-19 patients are mainly “Shieweiyang”, “Shierefu”, “Shirexifei, Feishixuanjiang” Syndromes, but we should be alert to prevent the disease from developing to “Feiqiyujue” syndrome